In the media this week: Aubrey, AI, and advocacy

Trust your doctor to diagnose you correctly? The Washington Post reports that 2/3 of doctors treating dementia patients backpedal on treatment plans after PET scan for amyloid deposits.


Preventative care pioneer and longevity hero Shigheaki Hinohara drove life expectancy to the very top, and used his own advice to live to the ripe old age of 105. Some evidence suggests that following in his footsteps and avoiding modifiable risk factors could prevent up to a third of dementia cases.


Rejuvenaction explores Aubrey de Grey’s two favorite arguments in favor of life extension’s ethical permissibility.


Why do so many people with good heart health still die of cardiovascular disease? It turns out that when it comes to immune defenses, sometimes the cure is worse than the disease…

immune defenses

Some major money is flowing into the intersection of anti-aging drug development and AI with new startup Juvenescence, whose founders hope to build a streamlined pipeline straight to your shelves. In related news, will R&D at existing pharma companies get boost from a proposed tax holiday?


You may think campaigning for longevity is all fun and games, but Elina Milova of the Life Extension Advocacy Foundation is here to tell you why serious, dedicated resources are what’s needed


Article originally posted at

Click here for the full story

Privacy Policy / Terms Of Use

       Powered by MMD